| 1 Failure to achieve complete resolution |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 1.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 2 Failure to achieve complete resolution (long term) |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 2.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 3 Erythema - Failure to achieve complete resolution |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 3.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 4 Erythema - Failure to achieve complete resolution (long term) |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 4.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 5 Pruritus - Failure to achieve complete resolution |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 5.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 6 Pruritus - Failure to achieve complete resolution (long term) |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 6.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 7 Scaling - Failure to achieve complete resolution |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 7.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 8 Scaling - Failure to achieve complete resolution (long term) |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 8.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 9 Side effects |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
| 9.1 Face only |
1 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |